Healthcare & Biotech
-
Fabric’s $60M Boost to Revolutionize Healthcare
Fabric secures $60M Series A funding, led by General Catalyst and others. AI-driven platform aims to reduce clinician burnout.
-
India’s Deep Tech: AI and Biotech Lead Boom
AI and biotech lead investments in India, with 80% funding since 2010. Biotech post-COVID surge sees $900M by 2023.
-
Unlearn Raises $50M to Revolutionize Clinical Trials
Unlearn raised $50M in Series C led by Altimeter Capital, using AI for digital twins, gaining regulatory milestones, and expanding.
-
Amply Nets £1.4M for AI Drug Discovery
Amply secures £1.4M grants for AI drug discovery targeting leukemia and MDR-TB. Plans to raise £1.4M more. Supported by key investors.
-
AI Predicts Psychosis with 85% Accuracy
Machine learning predicts psychosis with 85% accuracy using MRI brain scans from over 2000 individuals globally. Early diagnosis benefits.
-
AIIMS’s iOncology.ai Revolutionizes Cancer Diagnosis
AIIMS New Delhi and CDAC Pune developed iOncology.ai, an AI platform improving early cancer detection, focusing on breast and ovarian cancers in India.
-
Aqemia: Pioneering AI in Drug Discovery
Aqemia secures €60m Series A funding to advance its AI and quantum-inspired drug discovery platform, with strategic industry collaborations.
-
AI Revolutionizes Pancreatic Cancer Prognosis
The ‘Molecular Twin’ AI platform from Cedars-Sinai Medical Center uses multi-omic data to predict survival in pancreatic cancer.
Eksentricity 